One-year clinical outcome after ablation with a novel multipolar irrigated ablation catheter for treatment of atrial fibrillation: potential implications for clinical use.

Publikation

One-year clinical outcome after ablation with a novel multipolar irrigated ablation catheter for treatment of atrial fibrillation: potential implications for clinical use.

Wissenschaftlicher Artikel/Review - 11.01.2016

Wakili Reza, Siebermair Johannes, Fichtner Stephanie, Sinner Moritz F, Klocker Eva, Olesch Lucia, Hilberath Jan N, Sarai Samira, Clauss Sebastian, Sattler Stefan, Kääb Stefan, Estner Heidi L

Zitation

Wakili R, Siebermair J, Fichtner S, Sinner M, Klocker E, Olesch L, Hilberath J, Sarai S, Clauss S, Sattler S, Kääb S, Estner H. One-year clinical outcome after ablation with a novel multipolar irrigated ablation catheter for treatment of atrial fibrillation: potential implications for clinical use. Europace 2016; 18:1170-8.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Europace 2016; 18

Veröffentlichungsdatum

11.01.2016

eISSN (Online)

1532-2092

Seiten

1170-8

Kurzbeschreibung/Zielsetzung

Pulmonary vein isolation (PVI) is an established therapy for atrial fibrillation (AF). However, PVI remains a time-consuming procedure. A novel multipolar irrigated radiofrequency (RF) ablation catheter (nMARQ™) is aiming to improve PVI. We investigated the influence on procedural parameters and assessed clinical outcomes after PVI using this novel catheter.